PMA device
Demipulse Model 103
LivaNova USA, Inc. · Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ, Class III) · First FDA decision Nov 23, 2016, newest Nov 23, 2016DepressionEpilepsy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Demipulse"
MAUDE reports
7
Brand "Demipulse", since 2015
PubMed studies
3
Mentioning "Demipulse"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Demipulse Model 103
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P970003-S200 · Decided Nov 23, 2016 · 184 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, autonomic nerve, implanted for epilepsy (LYJ) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Demipulse", any status and sponsor, newest update first.
No registered device study names "Demipulse".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Demipulse", and for the whole product code for context.
This brand
7 reports: 4 malfunction, 2 injury, 1 death
Whole product code LYJ
23,970 reports: 13,606 malfunction, 9,108 injury, 1,251 death
Newest reports for this brand
- VNS THERAPY DEMIPULSE DUO GENERATORMalfunction
CYBERONICS, INC./LIVANOVA USA, INC.
MW5146914 · Received Oct 12, 2023
Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Patient problem as coded: Insufficient Information
- DEMIPULSE GENERATORDeath
CYBERONICS / LIVANOVA USA, INC.
MW5117132 · Received Apr 28, 2023 · Event dated Apr 19, 2023
Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Device problem as coded: Break
Patient problem as coded: Atrial Fibrillation; Bradycardia; Fall; Bone Fracture(s); Low Blood Pressure/ Hypotension; Dizziness; Neck Pain; Diminished Pulse Pressure
16183473 · Received Jan 17, 2023 · Event dated Nov 30, 2022
Device type: Stimulator, Autonomic Nerve, Implanted (Depression) (MUZ)
Device problem as coded: Battery Problem: Low Impedance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1067-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Z-1068-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
- SenTiva, REF: 1000; SenTiva Duo, REF: 1000-D; Generators Part of the VNS Therapy System. Used for Vagus Nerve Stimulation (VNS).Open, Classified
Z-1072-2025 · Started Dec 12, 2024 · Posted by FDA Jan 31, 2025
Reason given: Vagus nerve stimulator generators may stop delivering stimulation due to an internal, mechanically activated component that may become stuck in a closed position, which may result in patients returning to baseline seizure frequency or depressive symptoms and in the longer term, patients may be required to undergo...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
27 more recall records with a free account
Published research
The most relevant PubMed records for "Demipulse"[tiab]. The summary above synthesizes these.
- Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
Schneider UC, Bohlmann K, Vajkoczy P, et al. · Acta Neurochir (Wien) · 2015Comparative Study
- Adverse Events and Complications Associated With Vagal Nerve Stimulation: An Analysis of the Manufacturer And User Facility Device Experience Database.
Lim YG, Ker JRX, Tan YL, et al. · Neuromodulation · 2024Review
- Evolution in VNS therapy for refractory epilepsy, experience with Demipulse devices at Ghent University Hospital.
El Tahry R, De Herdt V, Raedt R, et al. · Seizure · 2010Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LYJ.
- VNS Therapy SystemLivaNova USA, Inc. · PMA 2026
- Neurocybernetic Prosthesis (Ncp) SystemLivaNova USA, Inc. · PMA 2004
- Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.LivaNova USA, Inc. · PMA 2016
- Vns Therapy AspiresrLivaNova USA, Inc. · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.